ANGPT1 and diabetes mellitus: Intravitreal administration of Ang-1 was shown to reverse diabetes-induced damage to the retinal vasculature in rodent models by reducing EC injury and BRB breakdown, accompanied by reduced retinal endothelial nitric oxide synthase expression, nitric oxide levels, AKT and mitogen-activated protein kinase activity and ICAM-1 expression [61].